Radiation pneumonitis: old problem, new tricks

V Jain, AT Berman - Cancers, 2018 - mdpi.com
Radiation therapy is a major treatment modality for management of non-small cell lung
cancer. Radiation pneumonitis is a dose limiting toxicity of radiotherapy, affecting its …

[HTML][HTML] Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy

N Yegya-Raman, W Zou, K Nie, J Malhotra… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Radiation therapy (RT) represents an integral part of a multimodality treatment plan in the
definitive, preoperative and postoperative management of non-small cell lung cancer …

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung …

H Mayahara, K Uehara, A Harada, K Kitatani… - Radiation …, 2022 - Springer
Background Concurrent chemoradiotherapy (CCRT) followed by durvalumab is the standard
of care for unresectable locally-advanced non-small cell carcinoma (LA-NSCLC). However …

[HTML][HTML] Radiation therapy induced cardiac toxicity

JJ Hufnagle, SN Andersen, EV Maani - 2020 - europepmc.org
Radiation Therapy Induced Cardiac Toxicity - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis

K Katsui, T Ogata, K Watanabe, N Katayama, J Soh… - BMC cancer, 2019 - Springer
Background The relationship between lung dose-volume histogram (DVH) parameters and
radiation pneumonitis (RP) associated with induction concurrent chemoradiotherapy …

Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy

MS Kim, WS Koom, JH Cho, SY Kim, IJ Lee - Radiation Oncology, 2022 - Springer
Background Upper tract urothelial carcinoma (UTUC) is rare and the treatment for recurrent
or metastatic UTUC is unclear. We evaluated the outcomes of salvage and palliative …

Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non‐small cell lung cancer treated with …

T Abe, M Iino, S Saito, T Aoshika, Y Ryuno… - Thoracic …, 2022 - Wiley Online Library
Background In this study, we developed a simple method for evaluating achievement
degree of lung dose optimization in individual patients with locally advanced non‐small cell …

[HTML][HTML] Reirradiation for locoregionally recurrent non-small cell lung cancer

MAL Vyfhuis, S Rice, J Remick… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Locoregional failure in non-small cell lung cancer (NSCLC) remains high, and the
management for recurrent disease in the setting of prior radiotherapy is difficult. Retreatment …

[HTML][HTML] Radiation-induced coronary artery disease: a difficult clinical conundrum

A Kirresh, L White, A Mitchell, S Ahmad, B Obika… - Clinical Medicine, 2022 - Elsevier
Accelerated coronary artery disease seen following radiation exposure is termed 'radiation-
induced coronary artery disease'(RICAD) and results from both the direct and indirect effects …

Three-dimensional conformal radiotherapy-based or intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal …

WC Lin, CL Chang, HL Hsu, KSP Yuan, ATH Wu… - Cancers, 2019 - mdpi.com
Background: To date, intensity-modulated radiation therapy (IMRT) with concurrent
chemoradiotherapy (CCRT) and CCRT with standard fractionation three-dimensional …